Hint mode is switched on Switch off

Mirum Pharmaceuticals, ordinary share
US6047491013, MIRM

Add a stock to WL
Choose all Reset all
Mirum Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug ...
Mirum Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS).
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Mirum Pharmaceuticals, Inc.
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    MIRM
  • Placement
    18.07.2019
  • Lock up period
    180
  • Number of papers
    5,000,000
  • Volume of raised funds
    75 mln USD
  • Placement share
    21.72%
  • Final placement price
    15 USD
  • Price change since placement date
    73%
  • By capitalization
    345.24 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    MIRM
  • Placement
    09.01.2020
  • Lock up period
    180
  • Number of papers
    2,400,000
  • Volume of raised funds
    48 mln USD
  • Placement share
    9.45%
  • Final placement price
    20 USD
  • Price change since placement date
    29.75%
  • By capitalization
    507.8 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    MIRM
  • Placement
    15.12.2020
  • Lock up period
    180
  • Number of papers
    3,750,000
  • Volume of raised funds
    75 mln USD
  • Placement share
    12.82%
  • Final placement price
    20 USD
  • Price change since placement date
    29.75%
  • By capitalization
    585.01 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

News

08/05/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
28/02/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
11/01/2024 Mirum Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
08/01/2024 Mirum Pharmaceuticals: Results Of Operations And Financial Condition, Regulation Fd Disclosure, Financial Statements And Exhibits
18/12/2023 Mirum Pharmaceuticals: Other Events
All organization news

Domestic and international bonds of the issuer

Holders

Industry Leaders

Registration is required to get access.